This inventor holds 2 USPTO granted patents. Top assignees: Burroughs Wellcome Co., Glaxo Wellcome Inc.. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: Valentina Riveros-Rojas: Innovator in Immunoglobulin Stabilization
Introduction
Valentina Riveros-Rojas is a notable inventor based in Beckenham, GB. She has made significant contributions to the field of immunology, particularly in the stabilization of immunoglobulin compositions. With a total of 2 patents, her work has implications for therapeutic applications involving antibodies.
Latest Patents
One of her latest patents is titled "Method for stabilizing immunoglobulin compositions." This invention relates to a stabilized immunoglobulin composition that includes at least one immunoglobulin along with a stabilizing amount of a chelator of copper ions, such as EDTA or citrate. The immunoglobulin is preferably an antibody, specifically a recombinant CDR-grafted antibody against the CDw52 antigen, most notably CAMPATH-1H. The patent also describes a process for enhancing the stability of an immunoglobulin by subjecting it to a purification procedure that effectively removes copper ions, ensuring that the immunoglobulin is rendered substantially free from detectable copper ions, as verified by atomic absorption spectroscopy.
Career Highlights
Throughout her career, Valentina has worked with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and Burroughs Wellcome Co. Her experience in these organizations has contributed to her expertise in immunoglobulin research and development.
Collaborations
Valentina has collaborated with various professionals in her field, including her coworker Marjorie Smith, who has also made significant contributions to immunology.
Conclusion
Valentina Riveros-Rojas is a pioneering inventor whose work in stabilizing immunoglobulin compositions has the potential to advance therapeutic applications in medicine. Her contributions to the field are noteworthy and continue to influence research and development in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
